China Accessibility Construction Law promulgation and implementation reflects our country pay more attention to the protection of the legitimate rights and interests of the disabled. The Article 37 of China Accessibility Construction Law stipulates the providers and regulators of labels and package insert in braille for drugs, providing further legal protection for drug safety of persons with disabilities in the form of law. However, there is a gap in the connection between relevant regulations, and there are still some problems, such as unclear obligations and functions of the subject of relevant liability, lack of uniform writing norms for braille labels and package insert of drugs, provisions on legal liability, and supporting systems and measures need to be improved. In this regard, it is necessary to improve the convergence between regulations and solve the problem of the application of law, further clarify the respective obligations and scope of authority of the responsible parties, improve the management norms, writing norms and national standards of drug braille labels and package insert in China, supplement the provisions of legal liability, and provide certain policy and economic support from the State and society. Based on the existing problems, this essay puts forward relevant suggestions and measures, in order to better promote the implementation of the accessibility format version of drug labels and package insert.